{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T03:24:01Z","timestamp":1794799441203,"version":"4.9.1"},"reference-count":107,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903905"],"award-info":[{"award-number":["81903905"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015337","name":"Doctoral Start-up Foundation of Guangdong Medical University","doi-asserted-by":"publisher","award":["4SG22211G"],"award-info":[{"award-number":["4SG22211G"]}],"id":[{"id":"10.13039\/501100015337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Province Universities and Colleges Pearl River Scholar Fund","award":["4SG22006G"],"award-info":[{"award-number":["4SG22006G"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDM"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Rev-erb\u0251 (NR1D1) is a nuclear receptor superfamily member that plays a vital role in mammalian molecular clocks\nand metabolism. Rev-erb\u0251 can regulate the metabolism of drugs and the body's glucose metabolism, lipid metabolism, and adipogenesis.\nIt is even one of the important regulatory factors regulating the occurrence of metabolic diseases (e.g., diabetes, fatty\nliver). Metabolic enzymes mediate most drug metabolic reactions in the body. Rev-erb\u0251 has been recognized to regulate\ndrug metabolic enzymes (such as Cyp2b10 and Ugt1a9). Therefore, this paper mainly reviewed that Rev-erb\u0251 regulates I and\nII metabolic enzymes in the liver to affect drug pharmacokinetics. The expression of these drug metabolic enzymes (up-regulated\nor down-regulated) is related to drug exposure and effects\/ toxicity. In addition, our discussion extends to Rev-erb\u0251 regulating\nsome transporters (such as P-gp, Mrp2, and Bcrp), as they also play an essential role in drug metabolism. Finally, we\nbriefly describe the role and mechanism of nuclear receptor Rev-erb\u0251 in lipid and glucose homeostasis, obesity, and metabolic\ndisorders syndrome. In conclusion, this paper aims to understand better the role and mechanism of Rev-erb\u0251 in regulating\ndrug metabolism, lipid, glucose homeostasis, obesity, and metabolic disorders syndrome, which explores how to target Rev-erb\u0251\nto guide the design and development of new drugs and provide scientific reference for the molecular mechanism of new\ndrug development, rational drug use, and drug interaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Rev-erb\u0251 (NR1D1) is a nuclear receptor superfamily member that plays a vital role in mammalian molecular clocks\nand metabolism. Rev-erb\u0251 can regulate the metabolism of drugs and the body's glucose metabolism, lipid metabolism, and adipogenesis.\nIt is even one of the important regulatory factors regulating the occurrence of metabolic diseases (e.g., diabetes, fatty\nliver). Metabolic enzymes mediate most drug metabolic reactions in the body. Rev-erb\u0251 has been recognized to regulate\ndrug metabolic enzymes (such as Cyp2b10 and Ugt1a9). Therefore, this paper mainly reviewed that Rev-erb\u0251 regulates I and\nII metabolic enzymes in the liver to affect drug pharmacokinetics. The expression of these drug metabolic enzymes (up-regulated\nor down-regulated) is related to drug exposure and effects\/ toxicity. In addition, our discussion extends to Rev-erb\u0251 regulating\nsome transporters (such as P-gp, Mrp2, and Bcrp), as they also play an essential role in drug metabolism. Finally, we\nbriefly describe the role and mechanism of nuclear receptor Rev-erb\u0251 in lipid and glucose homeostasis, obesity, and metabolic\ndisorders syndrome. In conclusion, this paper aims to understand better the role and mechanism of Rev-erb\u0251 in regulating\ndrug metabolism, lipid, glucose homeostasis, obesity, and metabolic disorders syndrome, which explores how to target Rev-erb\u0251\nto guide the design and development of new drugs and provide scientific reference for the molecular mechanism of new\ndrug development, rational drug use, and drug interaction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892002290055240212074758","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T23:55:49Z","timestamp":1708991749000},"page":"2-12","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recent Advances in Hepatic Metabolic Regulation by the Nuclear Factor\nRev-erb\u0251"],"prefix":"10.2174","volume":"25","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[{"name":"College of Pharmacy, Guangdong Medical University, Dongguan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Guangdong Medical University, Dongguan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Guangdong Medical University, Dongguan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haishan","family":"Xia","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Guangdong Medical University, Dongguan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbin","family":"Tong","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Guangdong Medical University, Dongguan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Guangdong Medical University, Dongguan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0092-8674(89)90169-4","volume":"57","author":"Miyajima N.","year":"1989","unstructured":"Miyajima N.; Horiuchi R.; Shibuya Y.; Fukushige S.; Matsubara K.; Toyoshima K.; Yamamoto T.; Two erbA homologs encoding proteins with different T3 binding capacities are transcribed from opposite DNA strands of the same genetic locus. Cell  1989,57(1),31-39","journal-title":"Cell"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1210\/mend.8.8.7997240","volume":"8","author":"Dumas B.","year":"1994","unstructured":"Dumas B.; Harding H.P.; Choi H.S.; Lehmann K.A.; Chung M.; Lazar M.A.; Moore D.D.; A new orphan member of the nuclear hormone receptor superfamily closely related to Rev-Erb. Mol Endocrinol  1994,8(8),996-1005","journal-title":"Mol Endocrinol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1038\/srep05782","volume":"4","author":"Koren\u010di\u010d A.","year":"2014","unstructured":"Koren\u010di\u010d A.; Ko\u0161ir R.; Bordyugov G.; Lehmann R.; Rozman D.; Herzel H.; Timing of circadian genes in mammalian tissues. Sci Rep  2014,4(1),5782","journal-title":"Sci Rep"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1126\/science.aaw7365","volume":"367","author":"Ray S.","year":"2020","unstructured":"Ray S.; Valekunja U.K.; Stangherlin A.; Howell S.A.; Snijders A.P.; Damodaran G.; Reddy A.B.; Circadian rhythms in the absence of the clock gene Bmal1. Science  2020,367(6479),800-806","journal-title":"Science"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1038\/emm.2015.122","volume":"48","author":"Han H.S.","year":"2016","unstructured":"Han H.S.; Kang G.; Kim J.S.; Choi B.H.; Koo S.H.; Regulation of glucose metabolism from a liver-centric perspective. Exp Mol Med  2016,48(3),e218","journal-title":"Exp Mol Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e00416","DOI":"10.1042\/BSR20160385","volume":"36","author":"Adeva-Andany M.M.","year":"2016","unstructured":"Adeva-Andany M.M.; P\u00e9rez-Felpete N.; Fern\u00e1ndez-Fern\u00e1ndez C.; Donapetry-Garc\u00eda C.; Pazos-Garc\u00eda C.; Liver glucose metabolism in humans. Biosci Rep  2016,36(6),e00416","journal-title":"Biosci Rep"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3727\/105221618X15156018385515","volume":"18","author":"Chiang J.Y.L.","year":"2018","unstructured":"Chiang J.Y.L.; Ferrell J.M.; Bile acid metabolism in liver pathobiology. Gene Expr  2018,18(2),71-87","journal-title":"Gene Expr"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2021.02.011","volume":"75","author":"Boyer JL","year":"2021","unstructured":"Boyer JL; Soroka CJ; Bile formation and secretion: An update. J Hepatol  2021,75,190-201","journal-title":"J Hepatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/21623945.2022.2060719","volume":"11","author":"Yu B.","year":"2022","unstructured":"Yu B.; Pan J.B.; Yu F.Y.; The combination of nuclear receptor NR1D1 and ULK1 promotes mitophagy in adipocytes to ameliorate obesity. Adipocyte  2022,11(1),202-212","journal-title":"Adipocyte"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1101\/gad.281972.116","volume":"30","author":"Zhang Y.","year":"2016","unstructured":"Zhang Y.; Fang B.; Damle M.; Guan D.; Li Z.; Kim Y.H.; Gannon M.; Lazar M.A.; HNF6 and Rev-erb\u03b1 integrate hepatic lipid metabolism by overlapping and distinct transcriptional mechanisms. Genes Dev  2016,30(14),1636-1644","journal-title":"Genes Dev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1074\/jbc.M113.511766","volume":"289","author":"Li X.","year":"2014","unstructured":"Li X.; Xu M.; Wang F.; Kohan A.B.; Haas M.K.; Yang Q.; Lou D.; Obici S.; Davidson W.S.; Tso P.; Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1. J Biol Chem  2014,289(4),2396-2404","journal-title":"J Biol Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1476-5381.2008.00030.x","volume":"156","author":"Zollner G.","year":"2009","unstructured":"Zollner G.; Trauner M.; Nuclear receptors as therapeutic targets in cholestatic liver diseases. Br J Pharmacol  2009,156(1),7-27","journal-title":"Br J Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.drudis.2012.01.017","volume":"17","author":"Testa B.","year":"2012","unstructured":"Testa B.; Pedretti A.; Vistoli G.; Reactions and enzymes in the metabolism of drugs and other xenobiotics. Drug Discov Today  2012,17(11-12),549-560","journal-title":"Drug Discov Today"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","volume":"21","author":"Almazroo O.A.","year":"2017","unstructured":"Almazroo O.A.; Miah M.K.; Venkataramanan R.; Drug metabolism in the liver. Clin Liver Dis  2017,21(1),1-20","journal-title":"Clin Liver Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1124\/dmd.117.078105","volume":"46","author":"Zhang T.","year":"2018","unstructured":"Zhang T.; Zhao M.; Lu D.; Wang S.; Yu F.; Guo L.; Wen S.; Wu B.; REV-ERB \u03b1 Regulates CYP7A1 through repression of liver receptor homolog-1. Drug Metab Dispos  2018,46(3),248-258","journal-title":"Drug Metab Dispos"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1124\/dmd.118.080895","volume":"46","author":"Yu F.","year":"2018","unstructured":"Yu F.; Zhang T.; Guo L.; Wu B.; Liver receptor homolog-1 regulates organic anion transporter 2 and docetaxel pharmacokinetics. Drug Metab Dispos  2018,46(7),980-988","journal-title":"Drug Metab Dispos"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1242\/jcs.190959","volume":"129","author":"Okabe T.","year":"2016","unstructured":"Okabe T.; Chavan R.; Costa S.S.F.; Brenna A.; Ripperger J.A.; Albrecht U.; REV-ERB\u03b1 influences stability and nuclear localization of the glucocorticoid receptor. J Cell Sci  2016,129(21),4143-4154","journal-title":"J Cell Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"6346","DOI":"10.1046\/j.0014-2956.2001.02540.x","volume":"268","author":"Pascussi J.M.","year":"2001","unstructured":"Pascussi J.M.; Drocourt L.; Gerbal-Chaloin S.; Fabre J.M.; Maurel P.; Vilarem M.J.; Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Eur J Biochem  2001,268(24),6346-6358","journal-title":"Eur J Biochem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1074\/jbc.M107228200","volume":"277","author":"Gerbal-Chaloin S.","year":"2002","unstructured":"Gerbal-Chaloin S.; Daujat M.; Pascussi J.M.; Pichard-Garcia L.; Vilarem M.J.; Maurel P.; Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem  2002,277(1),209-217","journal-title":"J Biol Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bcp.2018.04.005","volume":"152","author":"Zhao M.","year":"2018","unstructured":"Zhao M.; Zhang T.; Yu F.; Guo L.; Wu B.; E4bp4 regulates carboxylesterase 2 enzymes through repression of the nuclear receptor Rev-erb\u03b1 in mice. Biochem Pharmacol  2018,152,293-301","journal-title":"Biochem Pharmacol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1097\/FPC.0b013e3282f12a61","volume":"17","author":"Takiguchi T.","year":"2007","unstructured":"Takiguchi T.; Tomita M.; Matsunaga N.; Nakagawa H.; Koyanagi S.; Ohdo S.; Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells. Pharmacogenet Genom  2007,17(12),1047-1056","journal-title":"Pharmacogenet Genom"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1016\/j.xphs.2017.04.071","volume":"106","author":"Oh J.H.","year":"2017","unstructured":"Oh J.H.; Lee J.H.; Han D.H.; Cho S.; Lee Y.J.; Circadian clock is involved in regulation of hepatobiliary transport mediated by multidrug resistance-associated protein 2. J Pharm Sci  2017,106(9),2491-2498","journal-title":"J Pharm Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1053\/j.gastro.2008.07.073","volume":"135","author":"Murakami Y","year":"2008","unstructured":"Murakami Y; Higashi Y; Matsunaga N; Koyanagi S; Ohdo S; Circadian clock-controlled intestinal expression of the multidrug-resistance gene mdr1a in mice. Gastroenterology  2008,135(5),1636-1644","journal-title":"Gastroenterology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1053\/j.gastro.2008.05.035","volume":"135","author":"Duez H.","year":"2008","unstructured":"Duez H.; van der Veen J.N.; Duhem C.; Pourcet B.; Touvier T.; Fontaine C.; Derudas B.; Baug\u00e9 E.; Havinga R.; Bloks V.W.; Wolters H.; van der Sluijs F.H.; Vennstr\u00f6m B.; Kuipers F.; Staels B.; Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha. Gastroenterology  2008,135(2),689-698","journal-title":"Gastroenterology"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.11569\/wcjd.v18.i3.294","volume":"18","author":"Liu D.","year":"2010","unstructured":"Liu D.; Zhang C.L.; Yang Y.; Xiang D.C.; Gao J.; Wang X.T.; Expression and metabolic activity of carboxylesterases in human colorectal carcinoma Caco-2 cells. World Chin J Digesto  2010,18(3),294-297","journal-title":"World Chin J Digesto"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3870\/yydb.2011.02.009","volume":"30","author":"Liu D.","year":"2011","unstructured":"Liu D.; Zhang C.; Xiang D.; Xu Y.; Effect of CES2 in rat liver and intestines on the site-specific metabolism of lrinotecan. Med Rev  2011,30,166-170","journal-title":"Med Rev"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/00498254.2022.2128934","volume":"52","author":"Zhang L.","year":"2022","unstructured":"Zhang L.; Zhang F.; Xiao Y.; Du J.; Zhang X.; Chen M.; Wu B.; The nuclear receptor REV-ERB\u03b1 regulates CYP2E1 expression and acetaminophen hepatotoxicity. Xenobiotica  2022,52(6),633-643","journal-title":"Xenobiotica"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1124\/dmd.119.088450","volume":"47","author":"Chen M.","year":"2019","unstructured":"Chen M.; Guan B.; Xu H.; Yu F.; Zhang T.; Wu B.; The molecular mechanism regulating diurnal rhythm of flavin-containing monooxygenase 5 in mouse liver. Drug Metab Dispos  2019,47(11),1333-1342","journal-title":"Drug Metab Dispos"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.1111\/bph.14828","volume":"176","author":"Zhao M.","year":"2019","unstructured":"Zhao M.; Zhao H.; Deng J.; Guo L.; Wu B.; Role of the CLOCK protein in liver detoxification. Br J Pharmacol  2019,176(24),4639-4652","journal-title":"Br J Pharmacol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"764124","DOI":"10.3389\/fphar.2021.764124","volume":"12","author":"Chen M.","year":"2021","unstructured":"Chen M.; Chen M.; Lu D.; Wang Y.; Zhang L.; Wang Z.; Wu B.; Period 2 regulates CYP2B10 expression and activity in mouse liver. Front Pharmacol  2021,12,764124","journal-title":"Front Pharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.7150\/thno.28676","volume":"8","author":"Zhang T.","year":"2018","unstructured":"Zhang T.; Yu F.; Guo L.; Chen M.; Yuan X.; Wu B.; Small heterodimer partner regulates circadian cytochromes p450 and drug-induced hepatotoxicity. Theranostics  2018,8(19),5246-5258","journal-title":"Theranostics"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","volume":"7","author":"Mackenzie P.I.","year":"1997","unstructured":"Mackenzie P.I.; Owens I.S.; Burchell B.; Bock K.W.; Bairoch A.; B\u00e9langer A.; Gigleux S.F.; Green M.; Hum D.W.; Iyanagi T.; Lancet D.; Louisot P.; Magdalou J.; Roy Chowdhury J.; Ritter J.K.; Tephly T.R.; Schachter H.; Tephly T.; Tipton K.F.; Nebert D.W.; The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics  1997,7(4),255-269","journal-title":"Pharmacogenetics"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","volume":"99","author":"Meech R.","year":"2019","unstructured":"Meech R.; Hu D.G.; McKinnon R.A.; Mubarokah S.N.; Haines A.Z.; Nair P.C.; Rowland A.; Mackenzie P.I.; The UDP-Glycosyltransferase (UGT) Superfamily: New members, new functions, and novel paradigms. Physiol Rev  2019,99(2),1153-1222","journal-title":"Physiol Rev"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/00498254.2019.1617910","volume":"50","author":"Steventon G.","year":"2020","unstructured":"Steventon G.; Uridine diphosphate glucuronosyltransferase 1A1. Xenobiotica  2020,50(1),64-76","journal-title":"Xenobiotica"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1088458","DOI":"10.3389\/fonc.2022.1088458","volume":"12","author":"Liu W.","year":"2023","unstructured":"Liu W.; Li J.; Zhao R.; Lu Y.; Huang P.; The Uridine diphosphate (UDP)-glycosyltransferases (UGTs) superfamily: the role in tumor cell metabolism. Front Oncol  2023,12,1088458","journal-title":"Front Oncol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.taap.2008.02.020","volume":"230","author":"Erichsen T.J.","year":"2008","unstructured":"Erichsen T.J.; Ehmer U.; Kalthoff S.; Lankisch T.O.; M\u00fcller T.M.; Munzel P.A.; Manns M.P.; Strassburg C.P.; Genetic variability of aryl hydrocarbon receptor (AhR)-mediated regulation of the human UDP glucuronosyltransferase (UGT) 1A4 gene. Toxicol Appl Pharmacol  2008,230(2),252-260","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1053\/jhep.2001.24172","volume":"33","author":"Sugatani J.","year":"2001","unstructured":"Sugatani J.; Kojima H.; Ueda A.; Kakizaki S.; Yoshinari K.; Gong Q.H.; Owens I.S.; Negishi M.; Sueyoshi T.; The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology  2001,33(5),1232-1238","journal-title":"Hepatology"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1124\/dmd.106.013243","volume":"35","author":"Senekeo-Effenberger K.","year":"2007","unstructured":"Senekeo-Effenberger K.; Chen S.; Brace-Sinnokrak E.; Bonzo J.A.; Yueh M.F.; Argikar U.; Kaeding J.; Trottier J.; Remmel R.P.; Ritter J.K.; Barbier O.; Tukey R.H.; Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation. Drug Metab Dispos  2007,35(3),419-427","journal-title":"Drug Metab Dispos"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3109\/03602530903209544","volume":"42","author":"Mackenzie P.I.","year":"2010","unstructured":"Mackenzie P.I.; Hu D.G.; Gardner-Stephen D.A.; The regulation of UDP-glucuronosyltransferase genes by tissue-specific and ligand-activated transcription factors. Drug Metab Rev  2010,42(1),99-109","journal-title":"Drug Metab Rev"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1124\/dmd.32.8.775","volume":"32","author":"Bernard O.","year":"2004","unstructured":"Bernard O.; Guillemette C.; The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants. Drug Metab Dispos  2004,32(8),775-778","journal-title":"Drug Metab Dispos"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.3892\/ol.2016.5130","volume":"12","author":"Cui C.","year":"2016","unstructured":"Cui C.; Shu C.; Cao D.; Yang Y.; Liu J.; Shi S.; Shao Z.; Wang N.; Yang T.; Liang H.; Zou S.; Hu S.; UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens. Oncol Lett  2016,12(5),4231-4237","journal-title":"Oncol Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1124\/dmd.120.000030","volume":"48","author":"Xu H.","year":"2020","unstructured":"Xu H.; Chen M.; Yu F.; Zhang T.; Wu B.; Circadian clock component rev-erb \u03b1 regulates diurnal rhythm of udp-glucuronosyltransferase 1a9 and drug glucuronidation in mice. Drug Metab Dispos  2020,48(8),681-689","journal-title":"Drug Metab Dispos"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bcp.2019.01.010","volume":"161","author":"Zhang T.","year":"2019","unstructured":"Zhang T.; Guo L.; Yu F.; Chen M.; Wu B.; The nuclear receptor Rev-erb\u03b1 participates in circadian regulation of Ugt2b enzymes in mice. Biochem Pharmacol  2019,161,89-97","journal-title":"Biochem Pharmacol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1208\/s12248-022-00719-9","volume":"24","author":"Noh K.","year":"2022","unstructured":"Noh K.; Chow E.C.Y.; Quach H.P.; Groothuis G.M.M.; Tirona R.G.; Pang K.S.; Significance of the vitamin D receptor on crosstalk with nuclear receptors and regulation of enzymes and transporters. AAPS J  2022,24(4),71","journal-title":"AAPS J"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jaut.2018.07.022","volume":"94","author":"Xie A.","year":"2018","unstructured":"Xie A.; Robles R.J.; Mukherjee S.; Zhang H.; Feldbr\u00fcgge L.; Csizmadia E.; Wu Y.; Enjyoji K.; Moss A.C.; Otterbein L.E.; Quintana F.J.; Robson S.C.; Longhi M.S.; HIF-1\u03b1-induced xenobiotic transporters promote Th17 responses in Crohn\u2019s disease. J Autoimmun  2018,94,122-133","journal-title":"J Autoimmun"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"10505","DOI":"10.1038\/s41598-019-46977-0","volume":"9","author":"Okyar A.","year":"2019","unstructured":"Okyar A.; Kumar S.A.; Filipski E.; Piccolo E.; Ozturk N.; Xandri-Monje H.; Pala Z.; Abraham K.; Gomes A.R.G.J.; Orman M.N.; Li X.M.; Dallmann R.; L\u00e9vi F.; Ballesta A.; Sex-, feeding-, and circadian time-dependency of P-glycoprotein expression and activity - implications for mechanistic pharmacokinetics modeling. Sci Rep  2019,9(1),10505","journal-title":"Sci Rep"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1124\/mol.114.096735","volume":"88","author":"Iwasaki M.","year":"2015","unstructured":"Iwasaki M.; Koyanagi S.; Suzuki N.; Katamune C.; Matsunaga N.; Watanabe N.; Takahashi M.; Izumi T.; Ohdo S.; Circadian modulation in the intestinal absorption of P-glycoprotein substrates in monkeys. Mol Pharmacol  2015,88(1),29-37","journal-title":"Mol Pharmacol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"113622","DOI":"10.1016\/j.bcp.2019.08.024","volume":"169","author":"Zhou C.","year":"2019","unstructured":"Zhou C.; Yu F.; Zeng P.; Zhang T.; Huang H.; Chen W.; Wu B.; Circadian sensitivity to the cardiac glycoside oleandrin is associated with diurnal intestinal P-glycoprotein expression. Biochem Pharmacol  2019,169,113622","journal-title":"Biochem Pharmacol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.7150\/thno.33395","volume":"9","author":"Yu F.","year":"2019","unstructured":"Yu F.; Zhang T.; Zhou C.; Xu H.; Guo L.; Chen M.; Wu B.; The circadian clock gene bmal1 controls intestinal exporter MRP2 and drug disposition. Theranostics  2019,9(10),2754-2767","journal-title":"Theranostics"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/00498254.2023.2200839","volume":"53","author":"Wu C.","year":"2023","unstructured":"Wu C.; Xiao Y.; Wu C.; Xie D.; Luo M.; Yao D.; Chen M.; Lu D.; Regulation of BCRP expression and sulfasalazine pharmacokinetics by the nuclear receptor REV-ERB\u03b1. Xenobiotica  2023,53(3),215-222","journal-title":"Xenobiotica"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cphy.c170012","volume":"8","author":"Alves-Bezerra M.","year":"2017","unstructured":"Alves-Bezerra M.; Cohen D.E.; Triglyceride metabolism in the liver. Compr Physiol  2017,8(1),1-8","journal-title":"Compr Physiol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-981-15-6082-8_5","volume":"1276","author":"Pan X.","year":"2020","unstructured":"Pan X.; Mota S.; Zhang B.; Circadian clock regulation on lipid metabolism and metabolic diseases. Adv Exp Med Biol  2020,1276,53-66","journal-title":"Adv Exp Med Biol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3390\/ijms21062061","volume":"21","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Nakajima T.; Gonzalez F.J.; Tanaka N.; PPARs as metabolic regulators in the liver: Lessons from liver-specific PPAR-null mice. Int J Mol Sci  2020,21(6),2061","journal-title":"Int J Mol Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"10867","DOI":"10.1074\/jbc.M116.719120","volume":"291","author":"Jager J.","year":"2016","unstructured":"Jager J.; Wang F.; Fang B.; Lim H.W.; Peed L.C.; Steger D.J.; Won K.J.; Kharitonenkov A.; Adams A.C.; Lazar M.A.; The nuclear receptor rev-erb\u03b1 regulates adipose tissue-specific FGF21 signaling. J Biol Chem  2016,291(20),10867-10875","journal-title":"J Biol Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1016\/j.ajpath.2016.07.014","volume":"186","author":"Yang Z.","year":"2016","unstructured":"Yang Z.; Tsuchiya H.; Zhang Y.; Lee S.; Liu C.; Huang Y.; Vargas G.M.; Wang L.; REV-ERB\u03b1 activates C\/EBP homologous protein to control small heterodimer partner\u2013mediated oscillation of alcoholic fatty liver. Am J Pathol  2016,186(11),2909-2920","journal-title":"Am J Pathol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1080\/07420528.2023.2207649","volume":"40","author":"Ni Y.","year":"2023","unstructured":"Ni Y.; Nan S.; Zheng L.; Zhang L.; Zhao Y.; Fu Z.; Time-dependent effect of REV-ERB\u03b1 agonist SR9009 on nonalcoholic steatohepatitis and gut microbiota in mice. Chronobiol Int  2023,40(6),769-782","journal-title":"Chronobiol Int"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bcp.2017.02.006","volume":"131","author":"Sitaula S.","year":"2017","unstructured":"Sitaula S.; Zhang J.; Ruiz F.; Burris T.P.; Rev-erb regulation of cholesterologenesis. Biochem Pharmacol  2017,131,68-77","journal-title":"Biochem Pharmacol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","volume":"49","author":"Cobbina E.","year":"2017","unstructured":"Cobbina E.; Akhlaghi F.; Non-alcoholic fatty liver disease (NAFLD) \u2013 pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev  2017,49(2),197-211","journal-title":"Drug Metab Rev"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/hep.32671","volume":"78","author":"Zhong D.","year":"2023","unstructured":"Zhong D.; Cai J.; Hu C.; Chen J.; Zhang R.; Fan C.; Li S.; Zhang H.; Xu Z.; Jia Z.; Guo D.; Sun Y.; Inhibition of mPGES-2 ameliorates NASH by activating NR1D1 via heme. Hepatology  2023,78(2),547-561","journal-title":"Hepatology"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1161\/ATVBAHA.120.314368","volume":"40","author":"Yan H.","year":"2020","unstructured":"Yan H.; Niimi M.; Matsuhisa F.; Zhou H.; Kitajima S.; Chen Y.; Wang C.; Yang X.; Yao J.; Yang D.; Zhang J.; Murakami M.; Nakajima K.; Wang Y.; Liu E.; Liang J.; Chen Y.E.; Fan J.; Apolipoprotein CIII deficiency protects against atherosclerosis in knockout rabbits. Arterioscler Thromb Vasc Biol  2020,40(9),2095-2107","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1074\/jbc.M004982200","volume":"276","author":"Rasp\u00e9 E.","year":"2001","unstructured":"Rasp\u00e9 E.; Duez H.; Gervois P.; Fi\u00e9vet C.; Fruchart J.C.; Besnard S.; Mariani J.; Tedgui A.; Staels B.; Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. J Biol Chem  2001,276(4),2865-2871","journal-title":"J Biol Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"27120","DOI":"10.1074\/jbc.M203421200","volume":"277","author":"Coste H.","year":"2002","unstructured":"Coste H.; Rodr\u00edguez J.C.; Orphan nuclear hormone receptor Rev-erbalpha regulates the human apolipoprotein CIII promoter. J Biol Chem  2002,277(30),27120-27129","journal-title":"J Biol Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1210\/en.2009-0800","volume":"151","author":"Kumar N.","year":"2010","unstructured":"Kumar N.; Solt L.A.; Wang Y.; Rogers P.M.; Bhattacharyya G.; Kamenecka T.M.; Stayrook K.R.; Crumbley C.; Floyd Z.E.; Gimble J.M.; Griffin P.R.; Burris T.P.; Regulation of adipogenesis by natural and synthetic REV-ERB ligands. Endocrinology  2010,151(7),3015-3025","journal-title":"Endocrinology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"e1000181","DOI":"10.1371\/journal.pbio.1000181","volume":"7","author":"Le Martelot G.","year":"2009","unstructured":"Le Martelot G.; Claudel T.; Gatfield D.; Schaad O.; Kornmann B.; Sasso G.L.; Moschetta A.; Schibler U.; REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis. PLoS Biol  2009,7(9),e1000181","journal-title":"PLoS Biol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"Chiang J.Y.L.","year":"2020","unstructured":"Chiang J.Y.L.; Ferrell J.M.; Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol  2020,318(3),G554-G573","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"610496","DOI":"10.3389\/fgene.2020.610496","volume":"11","author":"Xing C.","year":"2020","unstructured":"Xing C.; Huang X.; Zhang Y.; Zhang C.; Wang W.; Wu L.; Ding M.; Zhang M.; Song L.; Sleep disturbance induces increased cholesterol level by NR1D1 mediated CYP7A1 inhibition. Front Genet  2020,11,610496","journal-title":"Front Genet"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e3348","DOI":"10.7717\/peerj.3348","volume":"5","author":"Li W.K.","year":"2017","unstructured":"Li W.K.; Li H.; Lu Y.F.; Li Y.Y.; Fu Z.D.; Liu J.; Atorvastatin alters the expression of genes related to bile acid metabolism and circadian clock in livers of mice. PeerJ  2017,5,e3348","journal-title":"PeerJ"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e002082","DOI":"10.1161\/CIRCGEN.118.002082","volume":"11","author":"Wang D.","year":"2018","unstructured":"Wang D.; Hartmann K.; Seweryn M.; Sadee W.; Interactions between regulatory variants in CYP7A1 (cholesterol 7\u03b1-hydroxylase) promoter and enhancer regions regulate CYP7A1 expression. Circ Genom Precis Med  2018,11(10),e002082","journal-title":"Circ Genom Precis Med"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s00125-020-05213-5","volume":"63","author":"Huising M.O.","year":"2020","unstructured":"Huising M.O.; Paracrine regulation of insulin secretion. Diabetologia  2020,63(10),2057-2063","journal-title":"Diabetologia"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"e149278","DOI":"10.1172\/jci.insight.149278","volume":"6","author":"Rahim M.","year":"2021","unstructured":"Rahim M.; Hasenour C.M.; Bednarski T.K.; Hughey C.C.; Wasserman D.H.; Young J.D.; Multitissue 2H\/13C flux analysis reveals reciprocal upregulation of renal gluconeogenesis in hepatic PEPCK-C\u2013knockout mice. JCI Insight  2021,6(12),e149278","journal-title":"JCI Insight"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e0142098","DOI":"10.1371\/journal.pone.0142098","volume":"10","author":"Li X.","year":"2015","unstructured":"Li X.; Xu M.; Wang F.; Ji Y.; DavidsoN W.S.; Li Z.; Tso P.; Interaction of ApoA-IV with NR4A1 and NR1D1 represses G6Pase and PEPCK transcription: Nuclear receptor-mediated downregulation of hepatic gluconeogenesis in mice and a human hepatocyte cell line. PLoS One  2015,10(11),e0142098","journal-title":"PLoS One"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1042\/BJ20121085","volume":"451","author":"Chini C.C.S.","year":"2013","unstructured":"Chini C.C.S.; Escande C.; Nin V.; Chini E.N.; DBC1 (Deleted in Breast Cancer 1) modulates the stability and function of the nuclear receptor Rev-erb\u03b1. Biochem J  2013,451(3),453-461","journal-title":"Biochem J"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1074\/jbc.M113.512913","volume":"289","author":"Nin V.","year":"2014","unstructured":"Nin V.; Chini C.C.S.; Escande C.; Capellini V.; Chini E.N.; Deleted in breast cancer 1 (DBC1) protein regulates hepatic gluconeogenesis. J Biol Chem  2014,289(9),5518-5527","journal-title":"J Biol Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"e69939","DOI":"10.1371\/journal.pone.0069939","volume":"8","author":"Vieira E.","year":"2013","unstructured":"Vieira E.; Marroqu\u00ed L.; Figueroa A.L.C.; Merino B.; Fernandez-Ruiz R.; Nadal A.; Burris T.P.; Gomis R.; Quesada I.; Involvement of the clock gene Rev-erb alpha in the regulation of glucagon secretion in pancreatic alpha-cells. PLoS One  2013,8(7),e69939","journal-title":"PLoS One"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.phrs.2019.01.010","volume":"141","author":"Yuan X.","year":"2019","unstructured":"Yuan X.; Dong D.; Li Z.; Wu B.; Rev-erb\u03b1 activation down-regulates hepatic Pck1 enzyme to lower plasma glucose in mice. Pharmacol Res  2019,141,310-318","journal-title":"Pharmacol Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00125-020-05140-5","volume":"63","author":"Schnurr T.M.","year":"2020","unstructured":"Schnurr T.M.; Jakupovi\u0107 H.; Carrasquilla G.D.; \u00c4ngquist L.; Grarup N.; S\u00f8rensen T.I.A.; Tj\u00f8nneland A.; Overvad K.; Pedersen O.; Hansen T.; Kilpel\u00e4inen T.O.; Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: A case-cohort study. Diabetologia  2020,63(7),1324-1332","journal-title":"Diabetologia"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.numecd.2020.11.022","volume":"31","author":"Ge Q.","year":"2021","unstructured":"Ge Q.; Qi Z.; Xu Z.; Li M.; Zheng H.; Duan X.; Chu M.; Zhuang X.; Comparison of different obesity indices related with hypertension among different sex and age groups in China. Nutr Metab Cardiovasc Dis  2021,31(3),793-801","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1681\/ASN.2006040327","volume":"17","author":"Chertow G.M.","year":"2006","unstructured":"Chertow G.M.; Hsu C.; Johansen K.L.; The enlarging body of evidence: Obesity and chronic kidney disease. J Am Soc Nephrol  2006,17(6),1501-1502","journal-title":"J Am Soc Nephrol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"e12682","DOI":"10.1111\/jpi.12682","volume":"69","author":"Li Y.","year":"2020","unstructured":"Li Y.; Ma J.; Yao K.; Su W.; Tan B.; Wu X.; Huang X.; Li T.; Yin Y.; Tosini G.; Yin J.; Circadian rhythms and obesity: Timekeeping governs lipid metabolism. J Pineal Res  2020,69(3),e12682","journal-title":"J Pineal Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41583-018-0088-y","volume":"20","author":"Logan R.W.","year":"2019","unstructured":"Logan R.W.; McClung C.A.; Rhythms of life: circadian disruption and brain disorders across the lifespan. Nat Rev Neurosci  2019,20(1),49-65","journal-title":"Nat Rev Neurosci"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2009-0014","volume":"31","author":"Froy O.","year":"2010","unstructured":"Froy O.; Metabolism and circadian rhythms--implications for obesity. Endocr Rev  2010,31(1),1-24","journal-title":"Endocr Rev"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1080\/10408398.2018.1556579","volume":"60","author":"Hern\u00e1ndez-Garc\u00eda J.","year":"2020","unstructured":"Hern\u00e1ndez-Garc\u00eda J.; Navas-Carrillo D.; Orenes-Pi\u00f1ero E.; Alterations of circadian rhythms and their impact on obesity, metabolic syndrome and cardiovascular diseases. Crit Rev Food Sci Nutr  2020,60(6),1038-1047","journal-title":"Crit Rev Food Sci Nutr"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1002\/cphy.c210011","volume":"12","author":"Crislip G.R.","year":"2021","unstructured":"Crislip G.R.; Johnston J.G.; Douma L.G.; Costello H.M.; Juffre A.; Boyd K.; Li W.; Maugans C.C.; Gutierrez-Monreal M.; Esser K.A.; Bryant A.J.; Liu A.C.; Gumz M.L.; Circadian rhythm effects on the molecular regulation of physiological systems. Compr Physiol  2021,12(1),2769-2798","journal-title":"Compr Physiol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41580-019-0179-2","volume":"21","author":"Patke A.","year":"2020","unstructured":"Patke A.; Young M.W.; Axelrod S.; Molecular mechanisms and physiological importance of circadian rhythms. Nat Rev Mol Cell Biol  2020,21(2),67-84","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1051\/medsci\/2003194411","volume":"19","author":"Teboul M.","year":"2003","unstructured":"Teboul M.; Delaunay F.; The orphan nuclear receptor Rev-erb alpha is a major component of the circadian clock. Med Sci  2003,19(4),411-413","journal-title":"Med Sci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"e111678","DOI":"10.1371\/journal.pone.0111678","volume":"9","author":"Vieira E.","year":"2014","unstructured":"Vieira E.; Ruano E.; Figueroa A.L.; Aranda G.; Momblan D.; Carmona F.; Gomis R.; Vidal J.; Hanzu F.A.; Altered clock gene expression in obese visceral adipose tissue is associated with metabolic syndrome. PLoS One  2014,9(11),e111678","journal-title":"PLoS One"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ijo.2012.117","volume":"37","author":"Goumidi L.","year":"2013","unstructured":"Goumidi L.; Grechez A.; Dumont J.; Cottel D.; Kafatos A.; Moreno L.A.; Molnar D.; Moschonis G.; Gottrand F.; Huybrechts I.; Dallongeville J.; Amouyel P.; Delaunay F.; Meirhaeghe A.; Impact of REV-ERB alpha gene polymorphisms on obesity phenotypes in adult and adolescent samples. Int J Obes  2013,37(5),666-672","journal-title":"Int J Obes"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1002\/mnfr.201300361","volume":"58","author":"Garaulet M.","year":"2014","unstructured":"Garaulet M.; Smith C.E.; Gomez-Abell\u00e1n P.; Ordov\u00e1s-Monta\u00f1\u00e9s M.; Lee Y.C.; Parnell L.D.; Arnett D.K.; Ordov\u00e1s J.M.; REV-ERB-ALPHA circadian gene variant associates with obesity in two independent populations: Mediterranean and North American. Mol Nutr Food Res  2014,58(4),821-829","journal-title":"Mol Nutr Food Res"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"e104065","DOI":"10.1371\/journal.pone.0104065","volume":"9","author":"Ruano E.G.","year":"2014","unstructured":"Ruano E.G.; Canivell S.; Vieira E.; REV-ERB ALPHA polymorphism is associated with obesity in the Spanish obese male population. PLoS One  2014,9(8),e104065","journal-title":"PLoS One"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1523\/JNEUROSCI.2710-15.2016","volume":"36","author":"Kentish S.J.","year":"2016","unstructured":"Kentish S.J.; Vincent A.D.; Kennaway D.J.; Wittert G.A.; Page A.J.; High-fat diet-induced obesity ablates gastric vagal afferent circadian rhythms. J Neurosci  2016,36(11),3199-3207","journal-title":"J Neurosci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/biolre\/iox158","volume":"98","author":"Crew R.C.","year":"2018","unstructured":"Crew R.C.; Waddell B.J.; Mark P.J.; Obesity-induced changes in hepatic and placental clock gene networks in rat pregnancy. Biol Reprod  2018,98(1),75-88","journal-title":"Biol Reprod"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature11030","volume":"485","author":"Solt L.A.","year":"2012","unstructured":"Solt L.A.; Wang Y.; Banerjee S.; Hughes T.; Kojetin D.J.; Lundasen T.; Shin Y.; Liu J.; Cameron M.D.; Noel R.; Yoo S.H.; Takahashi J.S.; Butler A.A.; Kamenecka T.M.; Burris T.P.; Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature  2012,485(7396),62-68","journal-title":"Nature"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.7150\/thno.43834","volume":"10","author":"Wang S.","year":"2020","unstructured":"Wang S.; Li F.; Lin Y.; Wu B.; Targeting REV-ERB\u03b1 for therapeutic purposes: Promises and challenges. Theranostics  2020,10(9),4168-4182","journal-title":"Theranostics"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1038\/s41467-021-25674-5","volume":"12","author":"Yu F.","year":"2021","unstructured":"Yu F.; Wang Z.; Zhang T.; Chen X.; Xu H.; Wang F.; Guo L.; Chen M.; Liu K.; Wu B.; Deficiency of intestinal Bmal1 prevents obesity induced by high-fat feeding. Nat Commun  2021,12(1),5323","journal-title":"Nat Commun"},{"key":"ref=95","first-page":"219","volume":"10","author":"Rinella M.E.","year":"2014","unstructured":"Rinella M.E.; Loomba R.; Caldwell S.H.; Kowdley K.; Charlton M.; Tetri B.; Harrison S.A.; Controversies in the diagnosis and management of NAFLD and NASH. Gastroenterol Hepatol  2014,10(4),219-227","journal-title":"Gastroenterol Hepatol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.2174\/13816128113199990381","volume":"19","author":"Dongiovanni P.","year":"2013","unstructured":"Dongiovanni P.; Anstee Q.; Valenti L.; Genetic predisposition in NAFLD and NASH: Impact on severity of liver disease and response to treatment. Curr Pharm Des  2013,19(29),5219-5238","journal-title":"Curr Pharm Des"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-981-10-8684-7_3","volume":"1061","author":"Farrell G.C.","year":"2018","unstructured":"Farrell G.C.; Haczeyni F.; Chitturi S.; Pathogenesis of NASH: How Metabolic complications of overnutrition favour lipotoxicity and pro-inflammatory fatty liver disease. Adv Exp Med Biol  2018,1061,19-44","journal-title":"Adv Exp Med Biol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"e0236000","DOI":"10.1371\/journal.pone.0236000","volume":"15","author":"Griffett K.","year":"2020","unstructured":"Griffett K.; Bedia-Diaz G.; Elgendy B.; Burris T.P.; REV-ERB agonism improves liver pathology in a mouse model of NASH. PLoS One  2020,15(10),e0236000","journal-title":"PLoS One"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"Mridha A.R.","year":"2017","unstructured":"Mridha A.R.; Wree A.; Robertson A.A.B.; Yeh M.M.; Johnson C.D.; Van Rooyen D.M.; Haczeyni F.; Teoh N.C.H.; Savard C.; Ioannou G.N.; Masters S.L.; Schroder K.; Cooper M.A.; Feldstein A.E.; Farrell G.C.; NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol  2017,66(5),1037-1046","journal-title":"J Hepatol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"4246","DOI":"10.1038\/s41467-018-06568-5","volume":"9","author":"Wang S.","year":"2018","unstructured":"Wang S.; Lin Y.; Yuan X.; Li F.; Guo L.; Wu B.; REV-ERB\u03b1 integrates colon clock with experimental colitis through regulation of NF-\u03baB\/NLRP3 axis. Nat Commun  2018,9(1),4246","journal-title":"Nat Commun"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1053\/j.gastro.2017.12.019","volume":"154","author":"Pourcet B.","year":"2018","unstructured":"Pourcet B.; Zecchin M.; Ferri L.; Beauchamp J.; Sitaula S.; Billon C.; Delhaye S.; Vanhoutte J.; Mayeuf-Louchart A.; Thorel Q.; Haas J.T.; Eeckhoute J.; Dombrowicz D.; Duhem C.; Boulinguiez A.; Lancel S.; Sebti Y.; Burris T.P.; Staels B.; Duez H.M.; Nuclear receptor subfamily 1 group D member 1 regulates circadian activity of NLRP3 inflammasome to reduce the severity of fulminant hepatitis in mice. Gastroenterology  2018,154(5),1449-1464","journal-title":"Gastroenterology"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2337\/diabetes.54.5.1314","volume":"54","author":"Biddinger S.B.","year":"2005","unstructured":"Biddinger S.B.; Almind K.; Miyazaki M.; Kokkotou E.; Ntambi J.M.; Kahn C.R.; Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes  2005,54(5),1314-1323","journal-title":"Diabetes"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cmet.2007.11.013","volume":"7","author":"Biddinger S.B.","year":"2008","unstructured":"Biddinger S.B.; Hernandez-Ono A.; Rask-Madsen C.; Haas J.T.; Alem\u00e1n J.O.; Suzuki R.; Scapa E.F.; Agarwal C.; Carey M.C.; Stephanopoulos G.; Cohen D.E.; King G.L.; Ginsberg H.N.; Kahn C.R.; Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab  2008,7(2),125-134","journal-title":"Cell Metab"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.2337\/db07-0480","volume":"56","author":"Croce M.A.","year":"2007","unstructured":"Croce M.A.; Eagon J.C.; LaRiviere L.L.; Korenblat K.M.; Klein S.; Finck B.N.; Hepatic lipin 1beta expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss. Diabetes  2007,56(9),2395-2399","journal-title":"Diabetes"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nm1044","volume":"10","author":"Koo S.H.","year":"2004","unstructured":"Koo S.H.; Satoh H.; Herzig S.; Lee C.H.; Hedrick S.; Kulkarni R.; Evans R.M.; Olefsky J.; Montminy M.; PGC-1 promotes insulin resistance in liver through PPAR-\u03b1-dependent induction of TRB-3. Nat Med  2004,10(5),530-534","journal-title":"Nat Med"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"22510","DOI":"10.1073\/pnas.0912533106","volume":"106","author":"Estall J.L.","year":"2009","unstructured":"Estall J.L.; Ruas J.L.; Choi C.S.; Laznik D.; Badman M.; Maratos-Flier E.; Shulman G.I.; Spiegelman B.M.; PGC-1\u03b1 negatively regulates hepatic FGF21 expression by modulating the heme\/Rev-Erb\u03b1 axis. Proc Natl Acad Sci  2009,106(52),22510-22515","journal-title":"Proc Natl Acad Sci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/bio.021519","volume":"6","author":"Chavan R.","year":"2017","unstructured":"Chavan R.; Preitner N.; Okabe T.; Strittmatter L.M.; Xu C.; Ripperger J.A.; Pitteloud N.; Albrecht U.; REV-ERB\u03b1 regulates Fgf21 expression in the liver via hepatic nuclear factor 6. Biol Open  2017,6(1),1-7","journal-title":"Biol Open"}],"container-title":["Current Drug Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892002290055240212074758","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/227262\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892002290055240212074758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T08:51:16Z","timestamp":1717059076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/227262\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892002290055240212074758","relation":{},"ISSN":["1389-2002"],"issn-type":[{"value":"1389-2002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}